The UK ME/CFS Biobank for biomedical research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis.
The UK ME/CFS Biobank was launched in August 2011 following extensive consultation with professionals and patient representatives. The bioresource aims to enhance research on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), related to pathophysiology, biomarkers and therapeutic approaches. The cohort includes 18-60 year olds, encompassing 284 clinically-confirmed ME/CFS cases, 60 neurologist-diagnosed multiple sclerosis (MS) cases, and 135 healthy individuals. The Biobank contains blood samples, aliquoted into serum, plasma, peripheral blood mononuclear cells (PBMC), red blood cells/granulocyte pellet, whole blood, and RNA (totalling 29,863 aliquots). Extensive dataset (700 clinical and socio-demographic variables/participant) enables comprehensive phenotyping. Potential reuse is conditional to ethical approval.
Item Type | Article |
---|
Explore Further
- Lacerda, Eliana M
- Bowman, Erinna
- Cliff, J
- Kingdon, CC
- King, Elizabeth
- Lee, J-S
- Clark, Taane G
- Dockrell, H
- Riley, Eleanor M
- Curran, H
- Nacul, Luis C
- Dept of Clinical Research
- ITD Distance Learning
- Department of Infection Biology
- Dept of Immunology and Infection (-2019)
- Dept of Infectious Disease Epidemiology
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482226 (OA Location)
- 10.5334/ojb.28 (DOI)
- 28649428 (PubMed)